[Combination of oral bacterial vaccines and antibiotics in acute recurrent respiratory infections].
The authors treated 34 patients with acute bronchopulmonary disease or flare-ups of chronic ones with equal doses of ambroxol and ceftriaxone considering the homogeneity of the morbid processes. Patients were divided into two groups of 17 subjects each: group A was given a polyvalent oral bacterial vaccine, group B a placebo. Relevant differences were found between the experimental and control groups concerning cough (score: A = 108, B = 119), duration of expectoration (A = 5.3 days, B = 6.4 days), duration of antibiotic therapy (A = 8.0 days, B = 8.8 days), and length of hospitalization (A = 10.9 days, B = 12.0 days). Differences were slight as far as duration of fever, characteristics of cough and objective findings on the chest were concerned.
Lauriello
G
G
I Divisione di Pneumotisiologia, USL N. 53, Presidio Ospedaliero G. da Procida, Salerno.
Giella
D
D
Berra
A
A
Matonti
V
V
D000208:Acute Disease; D000284:Administration, Oral; D000328:Adult; D000551:Ambroxol / Q000008:administration & dosage*; D001428:Bacterial Vaccines / Q000008:administration & dosage*; D001964:Bromhexine / Q000031:analogs & derivatives*; D002443:Ceftriaxone / Q000008:administration & dosage*; D003131:Combined Modality Therapy; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D012141:Respiratory Tract Infections / Q000188:drug therapy / Q000628:therapy*
D001428:Bacterial Vaccines; D000551:Ambroxol; D002443:Ceftriaxone; D001964:Bromhexine
Sull'associazione vaccino batterico orale e antibiotici in corso di infezioni respiratorie acute ricorrenti.